The Team
Marc-Antoine Guillen
Chairman
in the takeover of IC Bourse (formerly Via Bourse) from the end of 1998 before its merger with Banca Sella Group and then its sale to AVIVA. He was also involved in several privatisations (including that of Renault) and more than 100 stockmarket listings. In addition, with a wealth of multi-disciplinary experience, Marc-Antoine also works on mergers/acquisitions, fund raisings and private equity.
...
Jean-Emmanuel Vernay
CEO
He has been responsible for more than 100 stockmarket listings and has been an independent assessor approved by the AMF. The expertise of Jean-Emmanuel especially involves Equity Capital Market and Tech sector (biotech, medtech, IT, cleantech) operations.
....
Anne Bellavoine
Deputy CEO
in the cash equity market, responsible for equity sales in France. Chief Executive of SG Securities since 2003, Anne became global manager for equity sales in 2005 and Chairwoman of SG Securities Paris, and then Manager of the Global Equity Flow trading room in Paris in 2009. As from 2010, she worked as FIG banking adviser where she covered, in particular, the sector of French asset management and major US banks for SG CIB. She joined Carmignac Gestion as Marketing Manager and member of the strategic development committee in 2012. Since February 2015, she has assumed the General Management of the finance company, Jacques Cœur. Member of the SFAF, Anne has been a member of the “compliance and conformity” commission for more than 7 years (and is Joint Chairperson).
Pascal Hadjedj
Deputy General Manager
......
Thierry Roussilhe
Corporate Broking and Issuer Marketing Manager
....
Maxime DUBREIL
Manager of Secondary Market Research & Technologies Sector
...
Jamila EL BOUGRINI
Financial analyst - Biotech Jamila is a Financial Analyst dedicated to the Healthtech and Biotech sectors. She worked in several boutiques and Investment banks as a sell-side Equity Research Analyst such as Aurgalys, Bryan Garnier, Gilbert Dupont and Invest Securities. Before joining the financial world in 2015, Jamila worked as a Scientific Officer in the research funding field within two renowned institutions: Fondation ARC pour la Recherche sur le Cancer (national foundation dedicated to cancer research) and Vaincre la Mucoviscidose (Cystic Fibrosis national association). She holds a PhD in Cellular and Molecular Biology from University of Orsay (Paris – 2009), and a MBA from University of Dauphine / IAE of Sorbonne (Paris – 2015).